Clinical Trials
2
Active:1
Completed:1
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Post Market Observational Retrospective Study of Glycar Bovine Pericardial Patch (CIP-003)
Completed
- Conditions
- Cardiac DefectCardiac AnomalyPericardial Defect
- First Posted Date
- 2023-10-18
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- GLYCAR SA (Pty) Ltd
- Target Recruit Count
- 50
- Registration Number
- NCT06088680
- Locations
- 🇿🇦
Red Cross War Memorial Children's Hospital, Cape Town, Rondebosch, South Africa
GLYCAR Post Market Multicenter Study
Active, not recruiting
- Conditions
- Peripheral Vascular Reconstruction and RepairCardiac and Great Vessel Reconstruction and RepairCongenital Premature Cardiac Closure
- First Posted Date
- 2022-12-22
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- GLYCAR SA (Pty) Ltd
- Target Recruit Count
- 110
- Registration Number
- NCT05661981
- Locations
- 🇫🇷
Marie Lannelongue Hospital, Le Plessis-Robinson, France
🇩🇪Leipzig Heart Institute GmbH, Leipzig, Germany
🇩🇪German Heart Center Munich (Deutsches Herzzentrum München)- Adult Section, Munich, Germany
News
No news found